Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login
 Back To Article

  Reader Comments

Year : 2020 | Volume:  16 | Issue Number:  4

ORIGINAL ARTICLE

Post-progression survival is strongly linked to overall survival in refractory small-cell lung cancer patients who received amrubicin

Imai Hisao, Kaira Kyoichi, Mori Keita, Watase Nodoka, Hisada Takeshi, Yamada Masanobu, Minato Koichi

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks